VKTX
R500#10 today
$26.97
+5.89% today · -2.74% 1W
Oct 15 close or latest
ReadoutWhy it's moving
Weight-loss drug makers rise on oral development news
- VKTX +5.89% on the last session vs SPY +0.10%: +5.8 pts of stock-specific move.
- Weight-loss drugs: Eli Lilly and Novo Nordisk are developing oral weight-loss drugs, per BusinessWorld Online. (BusinessWorld Online)
- Weight-loss drugs basket +4.0% (+3.9 pts vs SPY; LLY +4.4%, NVO +3.7%): the stock moved with its peers.
- Market backdrop (Today): Core PPI m/m 1.3% vs 0.3% expected (hotter); Core Retail Sales m/m 0.9% vs 0.6% expected (stronger); S&P futures -0.08%, 10-year yield -3bp in the 30 minutes after.
Assembled from Wallsti's own signals and the session's headlines and filings read by AI (Claude); it can misread, so the sources are linked.
Mentions · past hour
—
Mentions · 24 hours
—
Mentions · 7 days
0
Avg sentiment · 24h
—
per mention, −1 to +1
What Reddit is saying
Not enough discussion in the past week.
Hottest comment
Viking Therapeutics Surges, Set To Break Out On Latest Obesity Drug Data
Somebody posted about VKTX surging Monday and they nailed it, too bad the post was made Friday after market close !img.
Top comments
No tracked comments in the past week.